Integral Health Asset Management, LLC Krystal Biotech, Inc. Transaction History
Integral Health Asset Management, LLC
- $859 Million
- Q1 2025
A detailed history of Integral Health Asset Management, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 60,000 shares of KRYS stock, worth $9.17 Million. This represents 1.26% of its overall portfolio holdings.
Number of Shares
60,000
Previous 55,000
9.09%
Holding current value
$9.17 Million
Previous $8.62 Million
25.56%
% of portfolio
1.26%
Previous 0.77%
Shares
11 transactions
Others Institutions Holding KRYS
# of Institutions
328Shares Held
24.2MCall Options Held
299KPut Options Held
97.6K-
Black Rock Inc. New York, NY3.95MShares$604 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.83MShares$432 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.73MShares$418 Million7.97% of portfolio
-
State Street Corp Boston, MA1.23MShares$188 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA954KShares$146 Million0.03% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $3.92B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...